These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular profiling of ADAM12 in human bladder cancer. Fröhlich C; Albrechtsen R; Dyrskjøt L; Rudkjaer L; Ørntoft TF; Wewer UM Clin Cancer Res; 2006 Dec; 12(24):7359-68. PubMed ID: 17189408 [TBL] [Abstract][Full Text] [Related]
3. Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer. Shimura T; Dagher A; Sachdev M; Ebi M; Yamada T; Yamada T; Joh T; Moses MA Cancer Prev Res (Phila); 2015 Mar; 8(3):240-8. PubMed ID: 25591790 [TBL] [Abstract][Full Text] [Related]
4. Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation. Nyren-Erickson EK; Bouton M; Raval M; Totzauer J; Mallik S; Alberto N J Negat Results Biomed; 2014 Apr; 13():5. PubMed ID: 24690292 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis. Taniguchi T; Asano Y; Akamata K; Aozasa N; Noda S; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):747-53. PubMed ID: 22540429 [TBL] [Abstract][Full Text] [Related]
6. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. Roy R; Wewer UM; Zurakowski D; Pories SE; Moses MA J Biol Chem; 2004 Dec; 279(49):51323-30. PubMed ID: 15381692 [TBL] [Abstract][Full Text] [Related]
7. Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment. Pories SE; Zurakowski D; Roy R; Lamb CC; Raza S; Exarhopoulos A; Scheib RG; Schumer S; Lenahan C; Borges V; Louis GW; Anand A; Isakovich N; Hirshfield-Bartek J; Wewer U; Lotz MM; Moses MA Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1034-42. PubMed ID: 18483323 [TBL] [Abstract][Full Text] [Related]
8. ADAM12 is a four-leafed clover: the excised prodomain remains bound to the mature enzyme. Wewer UM; Mörgelin M; Holck P; Jacobsen J; Lydolph MC; Johnsen AH; Kveiborg M; Albrechtsen R J Biol Chem; 2006 Apr; 281(14):9418-22. PubMed ID: 16455653 [TBL] [Abstract][Full Text] [Related]
9. Lithium might be associated with better decision-making performance in euthymic bipolar patients. Adida M; Jollant F; Clark L; Guillaume S; Goodwin GM; Azorin JM; Courtet P Eur Neuropsychopharmacol; 2015 Jun; 25(6):788-97. PubMed ID: 25840740 [TBL] [Abstract][Full Text] [Related]
10. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Nunes PV; Forlenza OV; Gattaz WF Br J Psychiatry; 2007 Apr; 190():359-60. PubMed ID: 17401045 [TBL] [Abstract][Full Text] [Related]
11. Analysis of polymorphisms in the alpha-subunit of the olfactory G-protein Golf in lithium-treated bipolar patients. Zill P; Malitas PN; Bondy B; Engel R; Boufidou F; Behrens S; Alevizos BE; Nikolaou CK; Christodoulou GN Psychiatr Genet; 2003 Jun; 13(2):65-9. PubMed ID: 12782961 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M; J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369 [TBL] [Abstract][Full Text] [Related]
14. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks. Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649 [TBL] [Abstract][Full Text] [Related]
15. EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study. Bilgin Doğru E; Dizdar Y; Akşit E; Ural F; Şanlı Ö; Yasasever V Tumour Biol; 2014 Nov; 35(11):11647-53. PubMed ID: 25139103 [TBL] [Abstract][Full Text] [Related]